Population pharmacokinetics of imatinib in patients with pulmonary arterial hypertension

被引:0
|
作者
Bouillon, Thomas [1 ]
Renard, Didier [1 ]
Zhou, Ping [2 ]
Flesch, Gerard [1 ]
Quinn, Debbie [3 ]
机构
[1] Novartis Pharma AG, Modeling & Simulat, CH-4002 Basel, Switzerland
[2] Novartis Horsham Res Ctr, Drug Metab & Pharmacokinet, Horsham, W Sussex, England
[3] Novartis Pharmaceut, Crit Care, E Hanover, NJ USA
关键词
Pulmonary hypertension;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
556
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
    Ghofrani, Hossein A.
    Morrell, Nicholas W.
    Hoeper, Marius M.
    Olschewski, Horst
    Peacock, Andrew J.
    Barst, Robyn J.
    Shapiro, Shelley
    Golpon, Heiko
    Toshner, Mark
    Grimminger, Friedrich
    Pascoe, Steve
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (09) : 1171 - 1177
  • [2] Population pharmacokinetics of riociguat in a pediatric population (aged ≥ 6 years) with pulmonary arterial hypertension
    Willmann, Stefan
    Keller, Andrea Kerstin
    Meyer, Michaela
    van Der Mey, Dorina
    Wirsching, Gabriela
    Zhang, Yang
    Drenth, Henk-Jan
    Keunecke, Anne
    Vendel, Esmee
    Saleh, Soundos
    PEDIATRIC PULMONOLOGY, 2023, 58 (03) : 908 - 917
  • [3] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension
    Kuwana, Masataka
    Abe, Kohtaro
    Kinoshita, Hideyuki
    Matsubara, Hiromi
    Minatsuki, Shun
    Murohara, Toyoaki
    Sakao, Seiichiro
    Shirai, Yuichiro
    Tahara, Nobuhiro
    Tsujino, Ichizo
    Takahashi, Kenta
    Kanda, Shingo
    Ogo, Takeshi
    PULMONARY CIRCULATION, 2023, 13 (01)
  • [4] Imatinib in pulmonary arterial hypertension: c-Kit inhibition
    Farha, Samar
    Dweik, Raed
    Rahaghi, Franck
    Benza, Raymond
    Hassoun, Paul
    Frantz, Robert
    Torres, Fernando
    Quinn, Deborah A.
    Comhair, Suzy
    Erzurum, Serpil
    Asosingh, Kewal
    PULMONARY CIRCULATION, 2014, 4 (03) : 452 - 455
  • [5] Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
    Hoeper, Marius
    Barst, Robyn
    Galie, Nazzareno
    Hassoun, Paul
    Morrell, Nicholas
    Peacock, Andrew
    Simonneau, Gerald
    Tapson, Victor
    Torres, Fernando
    Lawrence, David
    Quinn, Deborah
    Ghofrani, Hossein Ardeschir
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [6] Exercise in patients with pulmonary arterial with hypertension
    Desai, Smita A.
    Channick, Richard N.
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2008, 28 (01) : 12 - 16
  • [7] Rehabilitation in patients with pulmonary arterial hypertension
    Keusch, Stephan
    Turk, Alexander
    Saxer, Stephanie
    Ehlken, Nicola
    Grunig, Ekkehard
    Ulrich, Silvia
    SWISS MEDICAL WEEKLY, 2017, 147
  • [8] Metallomics in pulmonary arterial hypertension patients
    El-Kersh, Karim
    Hopkins, C. Danielle
    Wu, Xiaoyong
    Rai, Shesh N.
    Cave, Matthew C.
    Smith, M. Ryan
    Go, Young-Mi
    Jones, Dean P.
    Cai, Lu
    Huang, Jiapeng
    PULMONARY CIRCULATION, 2023, 13 (01)
  • [9] Burden Study of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension for Colombia Population
    Londono, Dario
    Villaquiran, Claudio
    Duenas, Ruben
    Taborda, Alejandra
    Rojas, Kamilo
    Chamorro, Cindy
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [10] Pharmacokinetic interactions of imatinib with bosentan and sildenafil for treatment of severe pulmonary arterial hypertension
    Renard, Didier
    Bouillon, Thomas
    Flesch, Gerard
    Zhou, Ping
    Quinn, Debbie
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42